Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Kenji Watanabe, Hisashi Shiga, Noritaka Takatsu, Shigeki Bamba, et al. Correction: Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD). Journal of gastroenterology. 2023. 58. 6. 602-603
Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, Shinichiro Shinzaki, Noritaka Takatsu, Toshimitsu Fujii, Ryuichi Okamoto, Katsuyoshi Matsuoka, Akihiro Yamada, Reiko Kunisaki, et al. Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD). Journal of Crohn's & colitis. 2023. 17. 8. 1193-1206
Noritaka Takatsu, Takashi Hisabe, Masahiro Kishi, Teruyuki Takeda, Shigeyoshi Yasukawa, Akihiro Koga, Ken Kinjo, Fumihito Hirai, Toshiharu Ueki, Kenshi Yao. Thiopurine naivety at tacrolimus induction is a predictor of long-term remission in patients with intractable ulcerative colitis who responded to tacrolimus. Journal of gastroenterology and hepatology. 2023. 38. 1. 52-60
Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Kenji Watanabe, Hisashi Shiga, Noritaka Takatsu, Shigeki Bamba, et al. Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD). Journal of gastroenterology. 2022. 57. 11. 867-878
2019 - JDDW2019 The Best Presenter Award in International Session Clinical outcome with Ustekinumab in medically-refractory Crohn's disease: real world experience from a single center cohort
2018 - APAGE 3rd Clinical Forum on Inflammatory Bowel Disease Young Investigator Award Short- and Long-term results of Tacrolimus therapy for Steroid-refractory Ulcerative colitis
2012 - 日本炎症性腸疾患研究会 Travel Award Efficacy of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus